Skip to main content

Table 2 Intraindividual comparison of lesion uptake FDG vs. Pentixafor

From: Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach

Patient no. Localization of the lesion Quantitative analyses Visual analyses Adeno/SCC CXCR4 expressionb
FDG SUVmax Pentixafor SUVmax FDGa Pentixafora
#1 paratracheal left 2.2 5.2 0 2 SCC 1
#2 mediastinal 10.1 3.2 2 0 SCC 4
infraclavicular 3.4 4.5 2 1
#3 hip 7.1 2.7 2 2 Adeno 1
thigh 10.5 3.9 2 2
adrenal gland left 3.3 2.9 2 2
left paraaortal lymph node 3.3 1.3 1 0
#4 esophagus 7.3 5.9 2 2 SCC 3
coeliacal 9,0 5,2 2 2
axillary right 0,85 1,73 0 2
hilary right 2,0 3,5 0 2
gastric curvature 5,6 4,1 2 2
#5 esophagus 6.6 6.5 2 2 Adeno 0
#6 mediastinal 14.4 4.2 2 0 Adeno 2
#7 mediastinal 15.8 4.8 2 2 SCC 3
#8 adrenal gland left 2.5 5.0 2 1 SCC 4
esophagus 3.3 3.9 1 0
lung upper lobe 4.9 1.5 2 0
#9 adrenal gland left 2.7 12.0 0 2 SCC 2
#10 infracarinal 2.7 9.1 0 2 SCC 4
mediastinal 4.1 9.8 1 2
supra right 2.2 5.4 0 2
supra left 2.8 6.6 0 2
esophagus 14.4 3.7 2 1
rib left 9.2 3.8 2 1
cervical left 13.7 4.1 2 1
SUM 26
  1. Adeno Adenocarcinoma, MPB Mediastinal blood pool, SCC Squamous cell cancer
  2. 0= < MBP, 1 ≥ MBP, 2 ≤ Liver
  3. b 0 = no CXCR4; 1 = low CXCR4; 2 = intermediate; 3 = strong; 4 = not available
\